InsidersTradesSigma
Follow the 바이젠셀 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 바이젠셀 has logged 2 public disclosures. Market capitalisation: €106.8bn. The latest transaction was filed on 31 March 2026 (Sale). Among the most active insiders: 가은글로벌. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
바이젠셀 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于开发创新的疾病治疗解决方案。